What a great adventure!
This last week, I was chatting with a medical specialist friend. We were discussing clinical trial data, COVID-19 and confirmation bias. The conversation drifted to real world data (RWD)/ evidence (RWE) and observational studies with historical controls. While I am … Read More »
This week was the yearly Head to the Hill event, organized by the National Brain Tumor Society. I participated in the trainings and today joined meetings with senate and congressional staffers. It was the first time I physically met with … Read More »
With my work, I often interact with Physicians, Hospitals and Life Sciences companies. Seldom do my discussions center around brain cancer, but I often think about how whatever I am doing could be applied to cancer patients like Susie and … Read More »
I recently received an email from Count Me In’s Brain Tumor Project, previously called the “Brain Cancer Project.” Susie and I participated in the launching of the effort with other patients, advocates and the Broad Institute. In addition to volunteering, … Read More »
This last week, we traveled to Houston for Susie’s cancer follow-up at MD Anderson’s Brain and Spine Center. This is the first time, since the pandemic started, we’ve physically met with Dr. O’Brien (her neuro-oncologist). Actually it has been even … Read More »
Last week Susie had her regularly scheduled cancer follow-up, which happens every four months. Let’s start with the most important detail, which is her scan results show her brain cancer is stable. Stable means no progression of disease, i.e. her … Read More »
After September’s unpresidential debate, see Presidential Debate Shit Show, we’ve seen Corona Virus (aka SARSCov2/ COVID19) take center stage. This is partly due to President Trump and some folks who attended the Supreme Court nomination announcement for Judge Amy Coney … Read More »
Yesterday and today I joined the 2020 National Conference for the American Brain Tumor Association (ABTA). While I enjoyed yesterday’s webinar sessions, I was particularly looking forward to two sessions being held today (Saturday), specifically a Brain Tumor Board (facilitated … Read More »
Back in May, I participated in the Head to the Hill event. The focus was to urge congressional representatives and senators to fund vital research and clinical trials that target brain cancer, like Glioblastoma Multiforme. On July 22nd, Glioblastoma Awareness … Read More »
This blog post is part of my Capstone Project for the IBM Data Science Professional Certification, offered via Coursera. I specifically documented some of the challenges and twists and turns that a lay person might encounter digging into publicly available … Read More »
Back in April, I wrote a blog post titled Corona Virus Observations. The post was really a back of the napkin analysis of US versus EU daily case and mortality rates. It showed the US case rates were higher than … Read More »
Most of my posts over the last six years have been related to Susie’s recurrence of brain cancer (a secondary glioblastoma in 2013). I also post about my professional work in artificial intelligence for healthcare and life sciences, as related … Read More »
Around six months ago, Susie and I talked about heading up to Washington, DC for the National Brain Tumor Society’s Head to the Hill event. I wanted to connect with other brain cancer advocates and help lend a voice to … Read More »